Most Popular
-
1
Seoul Fireworks Festival ends smoothly, but leaves piles of trash
-
2
[AtoZ into Korean mind] The price of numbers: How rankings shape lives in Korea
-
3
Yoon set for talks with Marcos in Philippines
-
4
Can Jennie break the K-pop solo artist slump?
-
5
Baseball star Hwang Jae-gyun, T-ara's Jiyeon file for divorce mediation
-
6
[Exclusive] Korea’s defense acquisition agency fails to meet legal standard for women representation
-
7
First lady’s Dior bag scandal to be at center of Assembly audit
-
8
2 US B-1B bombers conducted joint drill with S. Korean Air Force on Oct. 1 Armed Force Day
-
9
Firefighters’ 3,000 won meals spark nutrition concerns
-
10
Yoon honors veterans of Korean War in trip to Philippines
-
ASML CEO to visit Seoul next week
Dutch chip equipment giant ASML Holding’s CEO Peter Wennink will visit South Korea next week to attend the groundbreaking ceremony of the company’s new Korean headquarters, located in Hwaseong, Gyeonggi Province, that aims to bolster responsiveness to local client demands. Korea is home to Samsung Electronics and SK hynix, the world’s top two memory chipmakers, which take up more than 30 percent of ASML’s total sales. For the new facilities, the Dutch firm will spend a to
Nov. 7, 2022
-
Unity poised to help creating innovative games
Unity Technologies, developer of world-leading 3D graphics engines, discussed ways to improve the optimization and convenience for creators using its game-making tools at its annual Unite conference, the company’s Korea branch said Monday. The in-person Unite 2022 conference took place in Austin, Brighton in England, Copenhagen in Denmark, Montreal and San Francisco on Tuesday as it was also virtually open for all developers across the world. Headquartered in the US, Unity operates the wor
Nov. 7, 2022
-
Naver CEO voices confidence in data backup
Naver CEO Choi Soo-yeon on Monday underscored the IT giant’s data stability, pointing out that the company’s services are being provided soundly. “Established in 2013, data center Gak (Chuncheon) plays a linchpin role in offering (Naver’s) various services stably. With the high level of data backup and mirroring measures, we were able to normalize our services within a few hours in the wake of the recent fire at (SK C&C’s) data center,” said Choi in a conf
Nov. 7, 2022
-
US expansion matter of when, not if: Samsung Biologics
Samsung Biologics, the world's leading contract development and manufacturing organization by production capacity, is reviewing overseas expansion options with a determined will to set up a production foothold in the US in the future. "The US expansion is happening eventually. It's not about 'if.' It's about 'when,'" James Park, Samsung Biologics’ chief business officer, told a group of reporters last week at the Convention on Pharmaceutical Ingredients in Frankfurt, Germ
Nov. 7, 2022
-
[Graphic News] Deadly crowd crush spurs people's interest in CPR
The recent deadly crowd crush in Seoul sparked widespread interest among South Koreans in cardiopulmonary resuscitation that can help save lives during cardiac emergencies. Videos from Saturday's accident during Halloween festivities in Itaewon, which left 156 dead, showed not only rescue workers but also ordinary civilians desperately giving CPR to victims on the streets. Posts by people who performed CPR went viral on the internet, bringing home to people the importance of the emergency
Nov. 4, 2022
-
[Herald Interview] ‘One arm gets influenza, other arm gets COVID’
The novel coronavirus is likely to evolve into a flu-like respiratory virus by the end of 2023, or in 2024, once the COVID-19 pandemic reaches its endemic phase, eventually requiring people to get vaccinated year after year, a senior leader at Moderna said. “During the endemic period, the (COVID-19) vaccine will become available just like the influenza vaccine. You will be able to go online to a health center, do your pre-booking and pay for the vaccine exactly as you would for a flu vacci
Nov. 3, 2022
-
Samsung Biologics underscores commitment to sustainability
FRANKFURT, Germany -- Samsung Biologics’ top official on Wednesday stressed the importance of contract development and manufacturing organization companies’ efforts to reduce greenhouse gas emissions and how the South Korean CDMO giant is working toward achieving environmental friendliness. “CDMOs play a huge part because we provide the manufacturing and logistics for a lot of (biopharmaceutical) companies and we have to continue to innovate together,” said James Choi, ex
Nov. 3, 2022
-
Chinese EV battery makers gobbling up market share from Korean rivals
Chinese electric vehicle battery makers are quickly gobbling up market share from their South Korean rivals, largely buoyed by a surging demand at home, data showed Thursday. According to Seoul-based market tracker SNE Research, China’s CATL retained its top spot in global sales in the January-September period as it supplied 119.9 gigawatt-hours of batteries, more than doubling from a year ago. Its market share increased from 30.7 percent to 35.1 percent, widening the gap with Korea’
Nov. 3, 2022
-
Samsung appoints trade, energy specialists as new outside directors
Samsung Electronics on Thursday held an extraordinary shareholders meeting – the first in six years – to appoint two outside directors – Yoo Myung-hee, a former trade minister, and Heo Eun-nyeong, an economics professor. Yoo served as the nation’s top negotiator for free trade talks during the Moon Jae-in administration. She was also one of the final candidates to run for the director-general of the World Trade Organization in 2020. Yoo, a trade specialist, is expected to
Nov. 3, 2022
-
Proxy battle looms at Samsung as Lee Jae-yong tightens grip
Lee Jae-yong’s formal ascension to the top seat at Samsung Electronics, the crown jewel of the nation’s largest conglomerate, is fueling speculation about potential changes in the founding family’s governance structure across Samsung companies. His promotion to chairman has long been considered a crucial step for Lee to wield more power at Samsung. With the new title, Lee’s vision for a “New Samsung” will take a clearer shape, while stalled talks on mega deals
Nov. 2, 2022
-
[Exclusive] SK Pharmteco’s French CDMO to complete construction of new plant in Q1 2023
FRANKFURT, Germany -- Yposkesi, SK Pharmteco’s French contract development and manufacturing organization specialized in cell and gene therapy, is expecting to complete the construction of its new plant by the end of the first quarter next year, the CDMO’s CEO said Tuesday. “After (the completion of the plant), we will qualify this manufacturing unit and we expect to get the authorization from the French authorities to operate the plant under the (Good Manufacturing Practice) b
Nov. 2, 2022
-
[Herald Interview] ‘Biopharmas in midst of manufacturing revolution’
As biopharmaceutical companies across the globe are undergoing revolutionary changes in bioprocessing, Merck Life Science appears committed to helping Korean companies stay ahead of the game. Meeta Gulyani, head of strategy, business development and sustainability at Merck Life Science, told The Korea Herald last week that the factory of the future features connected, automated and digitized manufacturing. “All of this is to say that we are going to try to increase the speed of manufacturi
Nov. 2, 2022
-
Celltrion seeks partnership expansion at CPhI Worldwide
FRANKFURT -- Celltrion, a South Korean pharmaceutical giant, is seeking to expand partnerships at this year’s Convention on Pharmaceutical Ingredients Worldwide, the company said Tuesday. Taking place in major European cities each year, CPhI is one of the largest global pharma industry events in the world that gathers household names and experts. The German city of Frankfurt is holding this year’s event from Tuesday to Thursday. According to Celltrion, the drug maker has set up an in
Nov. 1, 2022
-
Samsung Biologics emphasizes speed
FRANKFURT, Germany -- Samsung Biologics, a leading South Korean contract development and manufacturing organization, has highlighted its speed in expanding production capacity and bringing clients’ drug products to the market as the company’s competitive edge in the global CDMO industry. “The most prominent differentiator is our speed to the market. We allow our customers to bring their products faster to the market,” said Kevin Sharp, Samsung Biologics’ vice presid
Nov. 1, 2022
-
Samsung Electronics marks 53rd anniversary in low-key
Samsung Electronics on Tuesday marked the 53rd anniversary of its foundation in a toned-down event, out of respect for the victims of the recent deadly Itaewon crowd crush. The annual event, held at a convention center in Suwon, Gyeonggi Province, is typically one of the Korean tech giant’s biggest celebrations. This year in particular, speculation was running high that recently promoted Chairman Lee Jae-yong would unveil concrete plans for his “New Samsung” vision. But the moo
Nov. 1, 2022
-
Instagram back after 8-hour global-wide service malfunction
Meta-owned social networking service Instagram said Tuesday its software bug, which resulted in a global-scale malfunction and affected random users, was fixed after eight hours. According to a US-based service outage-tracking website Downdetector, reports regarding the malfunction of Instagram soared starting around 10 p.m. Monday in Korea. Reports of the Instagram service malfunction soared from 305 at 9:48 p.m. to 7,300 at 11 p.m. Reported in-app type failures varied, such as suspension of ac
Nov. 1, 2022
-
Samsung's W130tr market cap evaporates in 10 months
Sixteen affiliates of South Korea's No. 1 business conglomerate Samsung have seen a drop in stock market cap by 129.36 trillion won ($90.78 billion) combined during the period of January to October, data showed Tuesday. This means nearly 20 percent of the market cap of the affiliates has evaporated compared to the end of 2021, according to the stock market data compiled by business intelligence Leaders Index. As a result, Samsung's 16 affiliates saw a total market cap of 541.8 trillion wo
Nov. 1, 2022
-
[Herald Interview] Strong intellectual property protection critical for drug innovation
Strong intellectual property protection is a key factor for pharmaceutical and biotechnology firms to become global household names, according to a high-ranking official at the International Federation of Pharmaceutical Manufacturers and Associations. “Because our industry is one of the most highly regulated industries, so what’s necessary in order to excel in that situation is, of course, the ability to innovate first and foremost. But that is only allowed through very strong intel
Oct. 31, 2022
-
Science Ministry mulls developing system to warn crowd crush
South Korea's science ministry is considering to develop a system that could warn authorities of potential crowd crush accidents by using digital data and technology to predict risk elements and the route of crowd movements. The new system was proposed at an emergency safety inspection meeting held by the Ministry of Science and ICT on Monday following the death of 154 people in a crowd crush that occurred Saturday evening during Halloween celebrations in Itaewon, central Seoul. “We h
Oct. 31, 2022
-
Naver to inject W5.2b for joint research on AI-based content with Univ. of Toronto
Naver said Monday it will inject 5.2 billion won ($3.6 million) over the next five years, along with Canadian social storytelling platform Wattpad which has become part of the company last year, to conduct joint research on AI-based content service platforms with the University of Toronto. South Korean internet giant said this study would allow application of advanced, exclusive technologies to Wattpad’s content platform leading to more innovative user experience. Naver bought Wattpad at
Oct. 31, 2022